Chinese scientists from the Ocean University of China, Shanghai Institute of medicine, the Materia Medica at the Chinese Academy of Sciences and of the company Green Valley Pharmaceutical Co., Ltd reported its success in the field of drug creation against Alzheimer’s disease, reports Xinhua. The tool is known as GV-971, and work on it is already 21 years.
The last stage of clinical trials is required before entering the market. It is known that in the study patients were given oral 450 milligrams of GV-971 twice a day for 36 weeks. And the tool significantly improved the condition of people. Experiments with animals were also successful.
The basis of the drug – an extract of brown algae. It can regulate the immune system, reduce inflammation in the nervous system and improve perception. All of this is critical for Alzheimer’s patients. To date, the disease has been diagnosed in approximately 48 million people worldwide. And there is still no effective drug on the market.